A detailed history of Neuberger Berman Group LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 12,656 shares of ACRS stock, worth $50,117. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,656
Previous 12,656 -0.0%
Holding current value
$50,117
Previous $13,000 7.69%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Nov 14, 2024

BUY
$1.01 - $1.36 $142 - $191
141 Added 1.13%
12,656 $13,000
Q2 2024

Aug 13, 2024

BUY
$1.01 - $1.36 $142 - $191
141 Added 1.13%
12,656 $13,000
Q1 2024

Nov 14, 2024

SELL
$0.92 - $1.44 $5,247 - $8,213
-5,704 Reduced 31.31%
12,515 $15,000
Q1 2024

May 13, 2024

BUY
$0.92 - $1.44 $11,513 - $18,021
12,515 New
12,515 $15,000
Q4 2023

Nov 14, 2024

BUY
$0.64 - $6.49 $3,560 - $36,103
5,563 Added 43.96%
18,219 $19,000
Q4 2023

Feb 09, 2024

BUY
$0.64 - $6.49 $11,660 - $118,241
18,219 New
18,219 $19,000

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $264M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.